Acorda was up 10% early yesterday on the posting of late-stage data for certain Parkinson’s patients, but then fell during the day.

Francis Collins remains NIH chief, but billions of dollars in cuts could be on the way.

The CEO of Akari Therapeutics has quit amid a probe into the release of phase 2 data and a related analyst report.

Sunovion released some devastating news ahead of the holiday weekend, as the FDA threw a spanner into its plans to bring a new drug for chronic obstructive…

Kite Pharma has secured a priority review at the FDA for its CAR-T candidate.

Scott Gottlieb, M.D., has ended the hiring freeze President Donald Trump imposed on the FDA.

GW Pharma's cannabis-based epilepsy treatment Epidiolex is firmly on track for a filing in the U.S. after new data published in the New England Journal of…

A panel of experts voted 12 to 4 in favor of approving Puma's breast cancer adjuvant therapy neratinib.

​​​​​​​Cel-Sci’s pitch to get a partial clinical hold lifted by the FDA has gone awry.

President Donald Trump’s administration has released a breakdown of its attempts to cut back on healthcare and research spending across the government, with…

Regulatory